CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 250 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $10,086 | +43.8% | 600 | 0.0% | 0.00% | – |
| Q3 2023 | $7,014 | +4.4% | 600 | +20.0% | 0.00% | – |
| Q2 2023 | $6,720 | +102.7% | 500 | +150.0% | 0.00% | – |
| Q1 2023 | $3,316 | +122.8% | 200 | +150.0% | 0.00% | – |
| Q4 2022 | $1,488 | +48.8% | 80 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -100.0% | 80 | -98.5% | 0.00% | – |
| Q1 2021 | $23,972,000 | +266255.6% | 5,200 | +108.0% | 0.00% | – |
| Q4 2019 | $9,000 | -60.9% | 2,500 | -44.4% | 0.00% | -100.0% |
| Q3 2019 | $23,000 | +155.6% | 4,500 | +80.0% | 0.00% | – |
| Q2 2019 | $9,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | +12.5% | 2,500 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |